Date Filed | Type | Description |
10/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
10/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
09/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/16/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/14/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
11/15/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/17/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
11/16/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/13/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/13/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/13/2018 |
5
| AFEYAN NOUBAR (10% Owner) has filed a Form 5 on Syros Pharmaceuticals, Inc. |